1. Home
  2. PDFS vs NBTX Comparison

PDFS vs NBTX Comparison

Compare PDFS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$34.18

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$30.18

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
NBTX
Founded
1992
2003
Country
United States
France
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
PDFS
NBTX
Price
$34.18
$30.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$33.67
$26.00
AVG Volume (30 Days)
246.1K
46.4K
Earning Date
05-07-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.13
N/A
Revenue Next Year
$18.92
$11.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.91
$2.99
52 Week High
$36.99
$41.89

Technical Indicators

Market Signals
Indicator
PDFS
NBTX
Relative Strength Index (RSI) 55.79 50.70
Support Level $30.72 $20.11
Resistance Level $34.97 $41.89
Average True Range (ATR) 1.54 2.57
MACD 0.06 -0.79
Stochastic Oscillator 79.33 14.51

Price Performance

Historical Comparison
PDFS
NBTX

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: